Back
Range Cancer Therapeutics ETF Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
47
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.24
Seasonality Move:
1.85%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- The current trend is moderately bullish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.35 | Sell |
| 20-day SMA: | 15.16 | Sell |
| 50-day SMA: | 15.07 | Buy |
| 200-day SMA: | 15.09 | Buy |
| 8-day EMA: | 15.36 | Sell |
| 20-day EMA: | 15.19 | Sell |
| 50-day EMA: | 15.04 | Buy |
| 200-day EMA: | 14.63 | Buy |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 49.2 | Sell |
| Chaikin Money Flow: | -5855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.71 - 15.45) | Buy |
| Bollinger Bands (100): | (14.08 - 15.46) | Buy |
Range Cancer Therapeutics ETF Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 15.09 while CNCR 8-day simple moving average is 15.35, which is a Sell signal.
- The stock price of CNCR is 15.09 while Range Cancer Therapeutics ETF 20-day SMA is 15.16, which makes it a Sell.
- Range Cancer Therapeutics ETF 50-day simple moving average is 15.07 while CNCR share price is 15.09, making it a Buy technically.
- CNCR stock price is 15.09 and Range Cancer Therapeutics ETF 200-day simple moving average is 15.09, creating a Buy signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
47
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a Sell
The current Range Cancer Therapeutics ETF [CNCR] share price is $15.09. The Score for CNCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
15.09
Share Volume:
2.2K
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
17.96
52-Week Low:
10.06
Sell
47
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?
The Range Cancer Therapeutics ETF stock price is 15.09 USD today. -
Will CNCR stock go up or go down?
Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators -
Is Range Cancer Therapeutics ETF overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 15.09 while CNCR 8-day exponential moving average is 15.36, which is a Sell signal.
- The stock price of CNCR is 15.09 while Range Cancer Therapeutics ETF 20-day EMA is 15.19, which makes it a Sell.
- Range Cancer Therapeutics ETF 50-day exponential moving average is 15.04 while CNCR share price is 15.09, making it a Buy technically.
- CNCR stock price is 15.09 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.63, creating a Buy signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
- CNCR Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Range Cancer Therapeutics ETF is a Buy
- Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 49.2, which suggest Range Cancer Therapeutics ETF is oversold
- The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (14.71 - 15.45), which suggest Range Cancer Therapeutics ETF is a Buy
- The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (14.08 - 15.46), which suggest Range Cancer Therapeutics ETF is a Buy
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.